Quarterly report · Q1

Period2023-12-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥13.4bn2023-12-01 → 2024-02-29Cons.Net sales
Revenue¥52.0bn2022-12-01 → 2023-11-30Cons.Net sales (5-year summary)
Revenue¥12.8bn2022-12-01 → 2023-02-28Cons.Net sales
Operating income¥454m2023-12-01 → 2024-02-29Cons.Operating income
Operating income−¥93m2022-12-01 → 2023-02-28Cons.Operating income
Ordinary income¥480m2023-12-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.4bn2022-12-01 → 2023-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income−¥64m2022-12-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥393m2023-12-01 → 2024-02-29Cons.Income before income taxes
Profit before tax−¥86m2022-12-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥249m2023-12-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-12-01 → 2023-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥207m2022-12-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥249m2023-12-01 → 2024-02-29Cons.Profit loss
Net income−¥208m2022-12-01 → 2023-02-28Cons.Profit loss
Total assets¥65.9bnat 2024-02-29Cons.Assets
Total assets¥67.3bnat 2023-11-30Cons.Assets
Total assets¥63.6bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥37.2bnat 2024-02-29Cons.Liabilities
Total liabilities¥38.7bnat 2023-11-30Cons.Liabilities
Net assets / equity¥28.7bnat 2024-02-29Cons.Net assets
Net assets / equity¥28.6bnat 2023-11-30Cons.Net assets
Net assets / equity¥26.5bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥4.7bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥6.9bnat 2023-11-30Cons.Cash and deposits
EPS (basic)¥6.322023-12-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.472022-12-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.252022-12-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
Equity ratio43.3%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio42.3%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio41.5%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 61
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-12-01 → 2024-02-29¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-12-01 → 2024-02-29¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-12-01 → 2024-02-29−¥31m
Reconciling Itemsreconcilingrevenue2023-12-01 → 2024-02-29−¥505m
Reconciling Itemsreconcilingrevenue intersegment2023-12-01 → 2024-02-29−¥505m
Reconciling Itemsreconcilingsegment profit2023-12-01 → 2024-02-29¥22m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue2023-12-01 → 2024-02-29¥5.9bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue external2023-12-01 → 2024-02-29¥5.5bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥371m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentsegment profit2023-12-01 → 2024-02-29¥76m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2023-12-01 → 2024-02-29¥3.0bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2023-12-01 → 2024-02-29¥3.0bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥14m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2023-12-01 → 2024-02-29¥93m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue external2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥20m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentsegment profit2023-12-01 → 2024-02-29¥112m
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue external2023-12-01 → 2024-02-29¥2.4bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥100m
jpcrp040300-q1r_E02585-000Medicalreportable segmentsegment profit2023-12-01 → 2024-02-29¥182m
—segment totalrevenue2023-12-01 → 2024-02-29¥13.9bn
—segment totalrevenue external2023-12-01 → 2024-02-29¥13.4bn
—segment totalrevenue intersegment2023-12-01 → 2024-02-29¥505m
—segment totalsegment profit2023-12-01 → 2024-02-29¥463m
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-02-29¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-02-29¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-12-01 → 2024-02-29¥505m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-02-29¥432m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-12-01 → 2023-02-28¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-12-01 → 2023-02-28¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-12-01 → 2023-02-28¥55,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-12-01 → 2023-02-28−¥23m
Reconciling Itemsreconcilingrevenue2022-12-01 → 2023-02-28−¥429m
Reconciling Itemsreconcilingrevenue intersegment2022-12-01 → 2023-02-28−¥429m
Reconciling Itemsreconcilingsegment profit2022-12-01 → 2023-02-28¥60m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue2022-12-01 → 2023-02-28¥4.9bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue external2022-12-01 → 2023-02-28¥4.6bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥341m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentsegment profit2022-12-01 → 2023-02-28¥26m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2022-12-01 → 2023-02-28¥4.2bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2022-12-01 → 2023-02-28¥4.2bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥10m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2022-12-01 → 2023-02-28−¥42m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥17m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentsegment profit2022-12-01 → 2023-02-28−¥105m
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥61m
jpcrp040300-q1r_E02585-000Medicalreportable segmentsegment profit2022-12-01 → 2023-02-28−¥9m
—segment totalrevenue2022-12-01 → 2023-02-28¥13.2bn
—segment totalrevenue external2022-12-01 → 2023-02-28¥12.8bn
—segment totalrevenue intersegment2022-12-01 → 2023-02-28¥429m
—segment totalsegment profit2022-12-01 → 2023-02-28−¥130m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-02-28¥13.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-02-28¥12.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-12-01 → 2023-02-28¥429m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-02-28−¥153m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Selling general and administrative expensesCurrentYTDDuration3797766000JPY
Operating incomePrior1YTDDuration-92929000JPY
Operating incomeCurrentYTDDuration454495000JPY
Interest income noiPrior1YTDDuration347000JPY
Interest income noiCurrentYTDDuration423000JPY
Dividends income noiPrior1YTDDuration24954000JPY
Dividends income noiCurrentYTDDuration23613000JPY
Rent income noiPrior1YTDDuration3561000JPY
Rent income noiCurrentYTDDuration1104000JPY
Foreign exchange gains noiPrior1YTDDuration-JPY
Foreign exchange gains noiCurrentYTDDuration4000JPY
Other noiPrior1YTDDuration41353000JPY
Other noiCurrentYTDDuration36210000JPY
Non operating incomePrior1YTDDuration70217000JPY
Non operating incomeCurrentYTDDuration61355000JPY
Interest expenses noePrior1YTDDuration14922000JPY
Interest expenses noeCurrentYTDDuration15704000JPY
Foreign exchange losses noePrior1YTDDuration3561000JPY
Foreign exchange losses noeCurrentYTDDuration-JPY
Equity in losses of affiliates noePrior1YTDDuration8168000JPY
Equity in losses of affiliates noeCurrentYTDDuration9350000JPY
Other noePrior1YTDDuration14799000JPY
Other noeCurrentYTDDuration10536000JPY
Non operating expensesPrior1YTDDuration41452000JPY
Non operating expensesCurrentYTDDuration35590000JPY
Ordinary incomePrior1YTDDuration-64164000JPY
Ordinary incomeCurrentYTDDuration480260000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1957000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration17000JPY
Extraordinary incomePrior1YTDDuration1957000JPY
Extraordinary incomeCurrentYTDDuration17000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration38000JPY
Loss on sales of noncurrent assets elCurrentYTDDuration-JPY
Loss on disposal of noncurrent assets elPrior1YTDDuration19224000JPY
Loss on disposal of noncurrent assets elCurrentYTDDuration18932000JPY
Loss on valuation of investment securities elPrior1YTDDuration-JPY
Loss on valuation of investment securities elCurrentYTDDuration50573000JPY
Loss on liquidation of subsidiaries and affiliates elPrior1YTDDuration4038000JPY
Loss on liquidation of subsidiaries and affiliates elCurrentYTDDuration-JPY
Loss on disaster elPrior1YTDDuration-JPY
Loss on disaster elCurrentYTDDuration17674000JPY
Extraordinary lossPrior1YTDDuration23302000JPY
Extraordinary lossCurrentYTDDuration87181000JPY
Income before income taxesPrior1YTDDuration-85508000JPY
Income before income taxesCurrentYTDDuration393096000JPY
Income taxes currentPrior1YTDDuration134545000JPY
Income taxes currentCurrentYTDDuration117904000JPY
Income taxes deferredPrior1YTDDuration-11634000JPY
Income taxes deferredCurrentYTDDuration26390000JPY
Income taxesPrior1YTDDuration122911000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-11-30pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-12-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-12-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-11-30pass
statement vs summary · total assetsconsolidated 2024-02-29pass